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Owing to its ability to induce growth arrest and
differentiation of keratinocytes, 1a,25-dihydroxy-
vitamin D3 and its analogs are useful for the treat-
ment of hyperproliferative skin diseases, such as
psoriasis vulgaris. It has been implicated that the
1a,25-dihydroxyvitamin D3-induced differentiation
of keratinocytes is mediated, at least in part, by the
formation of ceramides; however, ceramides have
also been identi®ed to induce apoptosis in many
cells, including keratinocytes. Therefore, it was of
interest to investigate the in¯uence of 1a,25-dihy-
droxyvitamin D3 on apoptosis in keratinocytes. Most
interestingly, physiological concentrations of 1a,25-
dihydroxyvitamin D3 did not induce apoptosis in
keratinocytes, despite the formation of ceramides.
Moreover, 1a,25-dihydroxyvitamin D3 appeared
cytoprotective and made keratinocytes resistant to
apoptosis induced by ceramides, ultraviolet irradi-
ation, or tumor necrosis factor-a. The cytoprotective
effect was accompanied by the formation of the
sphingolipid breakdown product sphingosine-1-phos-
phate, which prevented apoptosis in analogy to
1a,25-dihydroxyvitamin D3. The effect of 1a,25-
dihydroxyvitamin D3 was speci®c as the almost in-
active precursor cholecalciferol neither induced
sphingosine-1-phosphate formation nor prevented
cells from apoptosis. Besides this, the cytoprotective
aptitude of 1a,25-dihydroxyvitamin D3 was com-
pletely abolished by the sphingosine kinase inhibitor
N,N-dimethylsphingosine, which blocked sphingo-
sine-1-phosphate formation. Moreover, sphingosine-
1-phosphate was able to restore the cytoprotective
effect of 1a,25-dihydroxyvitamin D3 in the presence
of N,N-dimethylsphingosine. Taken together, here
we report for the ®rst time that 1a,25-dihydroxy-
vitamin D3 protects keratinocytes from apoptosis
and additionally this cytoprotection is mediated via
the formation of sphingosine-1-phosphate. Key
words: Bcl-2 family/cytoprotection/programmed cell death/
sphingolipids/vitamin D3. J Invest Dermatol 117:1241±
1249, 2001
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esides its long recognized role in calcium homeostasis,
1a,25-dihydroxyvitamin D3 (1,25-(OH)2D3) is known
to inhibit proliferation and to promote differentiation
in a variety of cell types, including breast and colon
carcinoma cells as well as leukemic and epidermal cells
(Bouillon et al, 1995; Kobayashi et al, 1998; Nolan et al, 1998).
Therefore, the therapeutic potential of 1,25-(OH)2D3 and its
derivatives (e.g., calcipotriol) has been investigated for the
treatment of cancer, acute myeloid leukemia, and psoriasis. 1,25-
(OH)2D3 exerts its effects by binding to the vitamin D3 receptor,
which belongs to the nuclear hormone-receptor gene family (Baker
et al, 1988). The hormone-receptor complex heterodimerizes with
the retinoid X receptor and binds to cognate response elements in
the promoters of target genes involved in the regulation of cell
growth and differentiation (Minghetti and Norman, 1988; Kuroki
et al, 1995). Recent studies have also indicated that 1,25-(OH)2D3
induces several rapid, apparently nongenomic biologic effects
in¯uencing a number of signal transduction pathways, including
phosphoinositide signaling, intracellular calcium increase, and
protein kinase C activation (Wali et al, 1990).
1,25-(OH)2D3 was the ®rst compound identi®ed as an inducer
of neutral Mg2+-dependent sphingomyelinase leading to the
hydrolysis of the membrane lipid sphingomyelin and a concomitant
increase of intracellular ceramide levels. Cell-permeable ceramide
analogs or bacterial sphingomyelinase mimic the effects of 1,25-
(OH)2D3 on cell differentiation (Bielawska et al, 1992b) indicating
an important role for ceramides in the actions of 1,25-(OH)2D3.
Moreover, ceramide has been identi®ed as a crucial component in
the induction of apoptosis. A variety of proapoptotic stimuli,
including tumor necrosis factor (TNF)-a, Fas-ligand, growth factor
withdrawal, anticancer drugs, oxidative stress, heat shock, ionizing
radiation as well as ultraviolet (UV) light have been found to
stimulate sphingomyelinase activity leading to an enhanced cellular
level of ceramide (Hannun and Obeid, 1995; Hannun, 1996; Jarvis
et al, 1996; Spiegel et al, 1996; Kolesnick and Kronke, 1998).
Indeed, in a number of cancer cells 1,25-(OH)2D3 has also been
recognized to induce apoptosis (Diaz et al, 2000; van den Bemd
et al, 2000; Wang et al, 2000). In contrast 1,25-(OH)2D3 fails to
induce programmed cell death in HL-60 cells as well as in human
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thyrocytes despite ceramide formation (Studzinski et al, 1986; Xu
et al, 1992, 1993; Wang and Studzinski, 1997). In fact, prolonged
incubation of HL-60 cells and thyrocytes with 1,25-(OH)2D3
prevents the appearance of apoptotic cell death induced by calcium
ionophores, anticancer drugs, and even cell-permeable ceramide
analogs. Anti-sense inhibition of vitamin D3 receptor expression
revealed that this protective effect is mediated via 1,25-(OH)2D3
binding to its nuclear receptor (Hewison et al, 1996).
Recently, we demonstrated that 1,25-(OH)2D3 enhances
sphingosine kinase activity in HL-60 cells leading to a concomitant
increase of sphingosine-1-phosphate (SPP), which prevents
ceramide-induced apoptosis (Kleuser et al, 1998).
Hydrolysis of sphingomyelin after stimulation with 1,25-
(OH)2D3 or calcipotriol has also been documented in keratino-
cytes. Here, 1,25-(OH)2D3 increases expression of TNF-a, which
induces ceramide formation via an autocrine mechanism (Geilen
et al, 1996, 1997). As TNF-a is in analogy to ceramides in a
classical inductor of apoptosis, it was of interest to investigate the
effect of 1,25-(OH)2D3 on keratinocyte survival. We found that
1,25-(OH)2D3 in physiological concentrations did not enhance
apoptosis in human keratinocytes despite the expression of TNF-a
and the subsequent formation of ceramide. Moreover, our studies
demonstrate for the ®rst time that 1,25-(OH)2D3 even protects
keratinocytes from apoptosis and this resistance is a consequence of
SPP formation.
MATERIALS AND METHODS
Materials 1,25-(OH)2D3 and calcipotriol were kindly donated by Dr.
Lise Binderup (Leo-Pharmaceutical Products, Ballerup, Denmark).
[methyl-3H]thymidine (35 Ci per mmol), [3H]putrescine (80 Ci per
mmol), and [g-32P]adenosine triphosphate (4500 Ci per mmol) were
purchased from ICN Biomedicals (Costa Mesa, CA). Cardiolipin and
standard phospholipids were from Avanti Polar Lipids (Birmingham, AL).
SPP, N,N-dimethylsphingosine (DMS), sphingosine, and N-
acetylsphingosine (C2-cer) were purchased from Biomol Research
Laboratory (Plymouth Meeting, PA). Annexin V-¯uorescein
isothiocyanate (Annexin V-FITC) was obtained from Bender (Vienna,
Austria). Dimethylcasein, putrescine, propidium iodide (PI), ceramides
(bovine brain, type III), leupeptin, aprotinin, dithiothreitol,
phenylmethylsulfonyl¯uoride, o-phthaldialdehyde, cholecalciferol, sodium
orthovanadate, deoxypyridoxine, bovine serum albumin, HEPES, Triton
X-100, actinomycin D, and Dulbecco's modi®ed Eagle's medium were
purchased from Sigma (St. Louis, MO). TNF-a was from Seromed
Biochrom (Berlin, Germany). Escherichia coli diacylglycerol kinase and
octyl-b-D-glycopyranosides were obtained from Calbiochem (La Jolla,
CA). Keratinocyte basal medium, epidermal growth factor, insulin,
hydrocortisone, bovine pituitary extract, gentamicin sulfate, and
amphotericin B were purchased from Clonetics (San Diego, CA). All
high-performance liquid chromatography solvents were obtained from
Merck (Darmstadt, Germany).
Cell culture To isolate human keratinocytes juvenile foreskin from
surgery was incubated at 4°C in a solution of 0.25% trypsin and 0.2%
ethylenediamine tetraacetic acid (EDTA) for 20 h. Trypsinization was
terminated by the addition of ice-cold Dulbecco's modi®ed Eagle's
medium containing 10% fetal bovine serum. Cells were washed with
phosphate-buffered saline (PBS) and centrifuged at 250 3 g for 5 min.
The pellet was resuspended in keratinocyte growth medium that was
prepared from keratinocyte basal medium by the addition of 0.1 ng per
ml recombinant epidermal growth factor, 5.0 mg insulin per ml, 0.5 mg
hydrocortisone per ml, 0.15 mM Ca2+, 30 mg bovine pituitary extract
per ml, 50 mg gentamicin sulfate per ml, 50 ng amphotericin B per ml.
Keratinocytes were pooled from several donors and cultured at 37°C
in 5% CO2. For all experiments only cells of the second or third passage
were used.
DNA synthesis Keratinocytes (4 3 104 cells per well) were grown in
24-well plates for 24 h. Then medium was replaced by fresh keratinocyte
growth medium and cells were incubated with 1,25-(OH)2D3 for 72 h.
Keratinocytes were pulsed with 1 mCi of [methyl-3H]thymidine per well
and incubated for 23 h. The medium was removed and cells were
washed twice each with PBS and ice-cold trichloroacetic acid (5%). The
precipitated material was dissolved in 0.3 M NaOH solution and
incorporated [methyl-3H]thymidine was determined in a scintillation
counter (MicroBeta Plus, Wallac Oy, Turku, Finland).
Sphingosine kinase activity Human keratinocytes grown in 100 mm
dishes until a con¯uence of approximately 60% were treated with
1,25(OH)2D3 or the indicated agents for various incubation periods.
Cells were then washed twice with ice-cold PBS and suspended in
200 ml of kinase buffer [20 mM Tris buffer (pH 7.4) containing 20%
(vol/vol) glycerol, 1 mM b-mercaptoethanol, 1 mM EDTA, 1 mM
sodium orthovanadate, 15 mM NaF, 10 mg per ml leupeptin and
aprotinin, 1 mM phenylmethylsulfonyl¯uoride, and 0.5 mM 4-
deoxypyridoxine] as described previously (Olivera and Spiegel, 1993).
Cells were disrupted by freeze-thawing, and the cytosolic fraction was
prepared by centrifugation at 13,000 3 g for 30 min at 4°C. The
cytosolic fraction (120 ml) was incubated with 10 ml of sphingosine
(1 mM), delivered as a sphingosine±bovine serum albumin complex
(4 mg bovine serum albumin per ml). Kinase buffer was added to a ®nal
volume of 190 ml, and reactions were started by adding 10 ml of
[g-32P]adenosine triphosphate (1±2 mCi, 20 mM) containing 100 mM
MgCl2. Samples were incubated for 30 min at 37°C, followed by the
addition of 20 ml of 1 M HCl. Lipids were extracted by the addition of
0.8 ml chloroform/methanol/concentrated HCl (100:200:1, vol/vol/vol).
After vigorous vortexing, 240 ml of chloroform and 240 ml of 2 M KCl
were added for phase separation. The samples were vortexed and
centrifuged. Labeled lipids in the organic phase were separated by thin-
layer chromatography on silica gel G60 using 1-butanol/methanol/acetic
acid/water (80:20:10:20, vol/vol/vol/vol) as the solvent. The radioactive
spots corresponding to authentic SPP were visualized by
autoradiography, scraped from the plates, and counted in a scintillation
counter.
Mass measurement of SPP SPP was determined as recently described
(Ruwisch et al, 2001). Brie¯y, keratinocytes were washed twice with
PBS and scraped in 1 ml of methanol containing 2.5 ml concentrated
HCl. Lipids were extracted by addition of 1 ml chloroform and 1 ml
1 M NaCl. For alkalization, 100 ml of a 3 M NaOH solution were
added. After centrifugation (300 3 g, 5 min), the alkaline aqueous phase
containing SPP was transferred into a siliconized glass tube, the organic
phase was re-extracted with 0.5 ml methanol, 0.5 ml 1 M NaCl and
50 ml 3 M NaOH. The aqueous phases were acidi®ed with 100 ml
concentrated HCl and extracted twice with 1.5 ml chloroform. The
combined organic phases were evaporated using a vacuum system
(Savant, Bethesda, MD). The dried lipids were resolved in 275 ml
methanol/0.07 M K2HPO4 (9:1) by rigorous vortexing and sonication
on ice for 5 min.
A derivatization mixture of 10 mg of o-phthaldialdehyde, 200 ml of
ethanol, 10 ml of b-mercaptoethanol, and 10 ml of a 3% boric acid
solution adjusted to pH 10.5 with potassium hydroxide was prepared.
25 ml of this derivatization mixture were added to the resolved lipids for
15 min at room temperature. The derivatives were analyzed by a Merck
Hitachi LaChrom high-performance liquid chromatography system
(Merck Hitachi, Darmstadt, Germany). Fluorescence was measured at an
emission wavelength of 455 nm and an excitation wavelength of 340 nm
after separation on a RP 18 Kromasil column (Chromatographie Service,
Langerwehe, Germany) kept at 35°C. The ¯ow rate was adjusted to
1.3 ml per min, methanol and 0.07 M K2HPO4 were used as eluents.
Resulting pro®les were evaluated using the Merck system manager
software.
Mass measurement of ceramide Keratinocytes, cultured in 100 mm
dishes, were treated with vehicle or 100 nM of 1,25-(OH)2D3 in the
presence or absence of 5 mM DMS. Then lipids were extracted by the
addition of 3 ml of methanol/chloroform/water (1:1:1, vol/vol/vol) and
an aliquot of 200 ml of the chloroform phase was dried under a nitrogen
stream. The lipids or standard bovine brain type III ceramides were
suspended in 40 ml of 7.5% (wt/vol) octyl-b-D-glycopyranoside, 5 mM
cardiolipin in 1 mM diethylenetriaminepentaacetic acid, 10 mM
imidazole (pH 6.6) and then solubilized by freeze-thawing followed by
sonication. The enzymatic reaction was started by the addition of 20 ml
of dithiothreitol (20 mM), 20 ml of Escherichia coli diacylglycerol kinase
(0.88 units per ml), 20 ml of [g-32P]adenosine triphosphate (10 mM,
1 mCi per nmol), and 100 ml of reaction buffer [100 mM imidazole
(pH 6.6), 100 mM NaCl, 25 mM MgCl2, and 2 mM ethyleneglycol-bis-
(b-aminoethylether)-N,N,N¢,N¢-tetraacetic acid]. Lipids were incubated
for 1 h at room temperature and then extracted by the addition of 1 ml
of chloroform/methanol/concentrated HCl (100:200:1, vol/vol/vol) and
170 ml of PBS containing 10 mM EDTA. An aliquot of 50 ml of the
organic phase was analyzed by thin-layer chromatography (Silica Gel
G60) with chloroform/acetone/methanol/acetic acid/water (10:4:3:2:1,
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vol/vol/vol/vol/vol) as the solvent. Radioactive spots corresponding to
ceramide-1-phosphate (Rf = 0.23 6 0.08) were counted.
Annexin V binding and PI dye exclusion by ¯ow
cytometry Keratinocytes (1.7 3 105 cells per well) were cultured in
keratinocyte basal medium containing 5.0 mg insulin per ml, 0.5 mg
hydrocortisone per ml, 50 mg gentamicin sulfate per ml, 50 ng
amphotericin B per ml and incubated with the indicated agents for 24 h.
Then cells were trypsinized and washed twice with binding buffer
(10 mM HEPES/NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl2).
Apoptosis was determined by ¯ow cytometric detection of
phosphatidylserine translocation using ¯uorescein-labeled Annexin V
(Vermes et al, 1997). To discriminate between early apoptotic cells
(Annexin V+/PI±) as well as late apoptotic and necrotic cells (Annexin
V+/PI+), dye exclusion of the nonvital dye PI was simultaneously
measured. Therefore, cells were resuspended in binding buffer followed
by the addition of Annexin V-FITC (®nal concentration 0.5 mg per ml).
The mixture was incubated for 10 min in the dark at room temperature,
washed, and resuspended in binding buffer. Then PI was added (1 mg
per ml) and samples were analyzed by bivariate ¯ow cytometry.
TUNEL staining Keratinocytes were directly stained on chamber
slides by the in situ cell death detection kit (Roche Diagnostics,
Mannheim, Germany), as recommended by the manufacturer. Cell layers
were ®xed with a 4% buffered paraformaldehyde solution and then
blocked with 3% H2O2 in methanol before permeabilization with 0.1%
Triton X-100 in 0.1% sodium citrate. Cells were incubated with
¯uorescein-labeled nucleotides (¯uorescein-deoxyuridine triphosphate)
and terminal deoxynucleotidyl transferase at 37°C for 1 h. Cells were
washed with PBS and incorporated ¯uorescein at the damaged sites of
the DNA was detected by an anti-¯uorescein antibody conjugated
horseradish peroxidase. After substrate reaction using diaminobenzidine,
approximately 100 cells were evaluated in randomly selected high-power
®elds by light microscopy. Negative control was obtained by replacing
the primary incubation with a nucleotide mixture without terminal
deoxynucleotidyl transferase.
Transglutaminase assay Transglutaminase activity was determined by
the method described by Wakita et al (1994). Cells were cultured in
keratinocyte growth medium and incubated with the test substances for
96 h. Keratinocytes were collected with a rubber policeman in 20 mM
Tris±HCl buffer containing 2 mM EDTA (pH 8.0) and homogenized by
freeze-thawing. After centrifugation at 600 3 g for 10 min, 100 ml of
the supernatant were mixed with 600 ml 50 mM Tris±HCl buffer
(pH 8.0) containing 10 mM CaCl2, 5 mM dithiothreitol, 540 mg
dimethylcasein, 1 mM putrescine, and 2.5 mCi [3H]putrescine (80 Ci per
mmol). The mixture was incubated for 1 h at 37°C and the enzymatic
reaction was stopped by the addition of 600 ml ice-cold trichloroacetic
acid (10%). The protein precipitate was washed three times with ice-cold
trichloroacetic acid (5%) containing 10 mM putrescine and once with
ethanol (95%). The pellet was solubilized in 200 ml 1 M NaOH solution
and radioactivity was determined in the scintillation counter.
Protein kinase C activity After treatment of keratinocytes with the
indicated agents for 24 h, cells were washed twice with PBS, scraped
from dishes, and suspended in kinase buffer [0.1 M Tris±HCl (pH 7.4)
containing 20% glycerol, 1 mM b-mercaptoethanol, 1 mM EDTA,
1 mM sodium orthovanadate, 15 mM NaF, 10 mg leupeptin per ml and
aprotinin each, 1 mM phenylmethylsulfonyl¯uoride, and 0.5 mM 4-
deoxypyridoxine]. Cells were lyzed by freeze-thawing and centrifuged at
140,000 3 g for 30 min. The supernatant, containing the cytosolic
fraction, was collected, whereas the pellet was resuspended by passing
through a 27 gauge needle 10 times in kinase buffer containing 0.1%
Triton X-100. After centrifugation at 140,000 3 g for 30 min,
supernatant was saved and designated as the membrane fraction. Protein
concentrations were determined and equal amounts from cytosolic and
membrane fractions were assayed for protein kinase C (PKC) activity,
using a commercial assay kit (Upstate Biotechnology, Inc, Lake Placid,
NY). The procedure was performed as described in the manufacturer's
instructions.
Immunoblot analysis for Bcl-2 The expression of Bcl-2 was
determined by western blot analysis using a mouse monoclonal antibody
to human Bcl-2 (PharMingen, San Diego, CA). Lysates of keratinocytes
were prepared by scraping cells from plates and suspended in PBS. The
cells were collected by centrifugation and the resulting pellets were
suspended in ice-cold lysis buffer [20 mM Tris±HCl (pH 7.4), 150 mM
NaCl, 1 mM Na2EDTA, 1 mM ethyleneglycol-bis-(b-aminoethylether)-
N,N,N¢,N¢-tetraacetic acid, 1% Triton X-100, 2.5 mM sodium
pyrophosphate, 1 mM b-glycerophosphate, 1 mM sodium orthovanadate
and 1 mg leupeptin per ml). After incubation on ice for 30 min, samples
were centrifuged at 13,000 3 g for 20 min. The Triton-soluble fraction
was collected, and 15 mg of protein were subjected to a 12.5%
polyacrylamide gel and transferred to nitrocellulose membranes. The
blots were blocked in Tris-buffered saline/Tween 20 (0.1%) with 5%
nonfat dry milk for 1 h, incubated with the primary antibody for 3 h at
37°C and a horseradish peroxidase-conjugated second antibody (New
England Biolabs, Beverly, MA) for 1 h at room temperature. Immune
complexes were detected with an enhanced chemoluminescence
detection method (Santa Cruz Biotechnology, CA).
Statistical analysis Data are the mean from triplicate assays and are
expressed as mean 6 SD. All experiments were repeated at least three
times independently. Statistics were performed using Student's t test,
with p < 0.05 considered signi®cant.
RESULTS
In¯uence of 1,25-(OH)2D3 on cell growth, apoptosis, and
necrosis 1,25-(OH)2D3 has been well established to inhibit cell
growth of human keratinocytes. In agreement with many previous
studies a slight but signi®cant anti-proliferative effect was visible
with 1 nM of 1,25-(OH)2D3, whereas a concentration of 100 nM
of 1,25-(OH)2D3 reduced [methyl-
3H]thymidine incorporation by
more than 60% (Table I). To prove whether the anti-proliferative
effect in this concentration range is accompanied by the induction
of apoptosis, we used TUNEL staining and additionally measured
the translocation of phosphatidylserine, an early event in the
apoptotic process, by ¯ow cytometry using Annexin V-FITC. To
distinguish between early apoptotic as well as late apoptotic and
Table I. Effect of 1,25-(OH)2D3 on proliferation, apoptosis and necrosis in human keratinocytes
a
1,25-(OH)2D3 Proliferation Apoptosis/necrosis
[methyl-3H] thymidine incorporation TUNEL-positive
cells (%)
Annexin V+/PI±
cells (%)
Annexin V+/PI+
cells (%)
(cpm 3 103) (% of control)
Control 53.3 6 5.5 100 14.7 6 2.5 3.4 6 0.7 7.5 6 2.1
0.1 nM 51.7 6 6.2 96 16.3 6 3.1 4.2 6 1.4 6.9 6 0.6
1 nM 41.1 6 4.9b 77 12.0 6 4.4 3.6 6 1.1 8.7 6 0.4
10 nM 29.0 6 6.5b 55 10.3 6 3.2 3.1 6 0.3 5.9 6 2.1
100 nM 21.7 6 5.7b 40 6.7 6 1.5b 3.4 6 1.2 8.4 6 1.4
1 mM 22.5 6 4.3b 42 29.7 6 8.0b 7.5 6 1.6b 64.5 6 8.9b
10 mM 19.5 6 4.1b 37 84.3 6 6.0b 8.7 6 3.4b 85.6 6 12.3b
aKeratinocytes were treated with the indicated concentrations of 1,25-(OH)2D3 for 3 d. Proliferation was measured by [methyl-
3H]thymidine incorporation as described
in Materials and Methods. Annexin V+/PI± and Annexin V+/PI+ cells were determined by ¯ow cytometric detection of phosphatidylserine translocation and PI uptake.
Additionally, TUNEL staining was performed. Data are mean 6 SD of triplicate determinations.
bp < 0.05 considered signi®cant.
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necrotic cells, dye exclusion of the nonvital dye PI was
simultaneously measured. It is of interest that 1±100 nM of 1,25-
(OH)2D3 neither increased Annexin V binding nor PI uptake
indicating that 1,25-(OH)2D3 did not possess apoptotic or necrotic
actions itself in this concentration range (Table I). But it should be
noted that 1,25-(OH)2D3 concentrations exceeding 1 mM,
however, resulted in an increased detachment of the cells from
the dishes. Indeed, measurement of apoptosis/necrosis
demonstrated an increase of Annexin V+/PI+-cells suggesting a
cytotoxic effect of 1,25-(OH)2D3 at concentrations above 1 mM
(Table I). This result was con®rmed by TUNEL staining and is in
agreement with other studies (Benassi et al, 1997; Bektas et al,
2000)
Protective effect of 1,25-(OH)2D3 on cell survival in
ceramide-, UV-, and TNF-a-induced apoptosis It has
been shown that treatment with 1,25-(OH)2D3 protects HL-60
cells and thyrocytes against ceramide-induced apoptosis. To
investigate an anti-apoptotic role of 1,25-(OH)2D3 in
keratinocytes, cells were treated with the cell permeable ceramide
analog C2-cer. Treatment with C2-cer resulted in an increase in
Annexin V+/PI± and more dramatically of Annexin V+/PI+ cells,
which is visible by a right shift of the cell populations presented in
Fig 1B. The ability of C2-cer to induce apoptosis became obvious
at a concentration of 25 mM; however, when keratinocytes were
preincubated with 100 nM of 1,25-(OH)2D3 Annexin V binding
and PI uptake was almost completely abolished indicating a
protective role for 1,25-(OH)2D3 against C2-cer induced apoptosis
(Fig 1C). The cytoprotective effect of 1,25-(OH)2D3 was veri®ed
using the TUNEL technique (Fig 2B). The capacity to prevent
apoptosis was dependent on the preincubation time with 1,25-
(OH)2D3. A signi®cant resistance against ceramide-induced
apoptosis was ®rst visible after a preincubation period of 12 h
with 1,25-(OH)2D3, whereas a maximal reduction of the number
of Annexin V+/PI± and Annexin V+/PI+ cells was evident after
24 h (Fig 2A). The effect was also concentration dependent
showing a maximal cytoprotection at 100 nM of 1,25-(OH)2D3.
Concentrations exceeding 1 mM did not prevent keratinocytes
from apoptosis, which is consistent with the cytotoxic effect of
1,25-(OH)2D3 (Fig 2B). As UV and TNF-a have been found to
increase ceramide levels, we investigated the effect of 1,25-
(OH)2D3 on Annexin V binding and PI uptake induced by these
stimuli. Indeed, 1,25-(OH)2D3 inhibited the expression of the
apoptotic traits induced by UV and TNF-a demonstrating a
protective effect of 1,25-(OH)2D3 independent of the apoptosis-
triggering stimulus (Fig 3).
To investigate the speci®city of 1,25-(OH)2D3 on cell survival,
keratinocytes were also preincubated with calcipotriol and
cholecalciferol. In analogy to the results with 1,25-(OH)2D3, a
resistance against apoptosis was also detected with 100 nM of
calcipotriol whereas pretreatment of keratinocytes with 100 nM of
cholecalciferol, the almost inactive precursor of 1,25-(OH)2D3,
neither diminished Annexin V binding nor PI uptake induced by
ceramide.
Protective effect of SPP on cell survival in ceramide-
induced apoptosis Recently, we have identi®ed SPP as a
regulatory component in the prevention of apoptosis in HL-60 cells
after treatment with 1,25-(OH)2D3. Therefore, we examined the
role of SPP on apoptosis in human keratinocytes. Cells were
pretreated with SPP followed by the incubation with C2-cer.
Exposure of keratinocytes to SPP prevented ceramide-induced
Figure 2. Effect of the 1,25-(OH)2D3-
preincubation time and the 1,25-(OH)2D3-
dose on prevention of ceramide-induced
apoptosis. Human keratinocytes were pretreated
with 100 nM of 1,25-(OH)2D3 for the indicated
time periods (A) or with the indicated
concentrations of 1,25-(OH)2D3 for 24 h (B).
Apoptosis was induced by addition of 25 mM C2-
cer for 3 h. Then double staining with Annexin
V-FITC and PI as well as TUNEL staining were
performed as described in Materials and Methods.
Data are the mean 6 SD of triplicate assays.
Figure 1. Flow cytometric analysis indicating
a protective effect of 1,25-(OH)2D3 against
ceramide-induced apoptosis in human
keratinocytes. Keratinocytes were preincubated
with either vehicle (A, B) or 100 nM of 1,25-
(OH)2D3 (C) for 24 h. Then C2-cer (25 mM) was
added (B, C) for 3 h. Cells were harvested and
double staining with Annexin V-FITC and PI was
performed as described in Materials and Methods.
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apoptosis corroborating other studies with HL-60 and U937 cells.
SPP suppressed C2-cer-induced Annexin V binding and PI uptake
by more than 55%. The resistance against apoptosis was
concentration dependent showing an optimal concentration at
10 mM SPP (Fig 4).
Involvement of SPP in the cytoprotective effect of 1,25-
(OH)2D3 We next investigated whether the protective effect of
1,25-(OH)2D3 is mediated by the formation of SPP. For this reason
the activity of sphingosine kinase, the critical enzyme in the
formation of SPP, was determined after exposure to 1,25-
(OH)2D3. Indeed, 1,25-(OH)2D3 increased sphingosine kinase
activity (Fig 5A). A signi®cant enhancement was ®rst detected
after 8 h and highest levels were observed after 24 h of exposure,
which correlates with the cytoprotective effect of 1,25-(OH)2D3.
The stimulation of sphingosine kinase was also concentration
dependent (Fig 5B). A slight increase occurred already at 1 nM of
1,25-(OH)2D3, whereas highest enzyme activities leading to an
1.7-fold increase were detected at 100 nM of 1,25-(OH)2D3.
During the time period of 24 h no phenotypic changes of
differentiation were detected as measured by transglutaminase
activity. Once more for the investigation of speci®city, the
in¯uence of calcipotriol and cholecalciferol on sphingosine kinase
activity was investigated. Calcipotriol (100 nM), which has been
shown to possess a cytoprotective effect, increased sphingosine
kinase activity in analogy to 1,25-(OH)2D3, whereas 100 nM of
cholecalciferol did not affect the enzyme activity.
To prove whether stimulation of sphingosine kinase activity is
associated with alterations of SPP mass levels, intracellular levels
were examined after exposure to 1,25-(OH)2D3. SPP formation
increased after treatment with 1,25-(OH)2D3 in accordance with
the stimulation of sphingosine kinase activity and the cytoprotec-
tive effect of 1,25-(OH)2D3. The levels of SPP started to rise after
12 h and reached highest levels after 24 h of exposure to 100 nM
of 1,25-(OH)2D3. At 24 h there was a signi®cant increase of mass
levels of SPP by almost 40% (Table II).
Effect of DMS on sphingosine kinase activity, ceramide
levels, and cytoprotection in the presence of 1,25-
(OH)2D3 To substantiate further the crucial role of SPP in the
cytoprotective effect of 1,25-(OH)2D3 in keratinocytes, we utilized
DMS, a well known inhibitor of sphingosine kinase. As there are
controversial reports indicating that DMS also inhibits PKC
activity, we measured the in¯uence of DMS on PKC and
sphingosine kinase activity after exposure to 1,25-(OH)2D3. The
addition of 5 mM DMS did not reduce membrane-associated PKC
activity in 1,25-(OH)2D3-treated keratinocytes (Fig 6A). In
contrast, enhancement of sphingosine kinase activity was
completely inhibited indicating that DMS is a speci®c inhibitor
of this enzyme in keratinocytes only (Fig 6B).
Treatment of keratinocytes with DMS augmented the level of
intracellular ceramides from 111.5 6 4.4 pmol per 105 cells to
128.2 6 3.1 pmol per 105 cells. In agreement Annexin V binding
and PI uptake were increased con®rming the crucial part played by
SPP in the prevention of apoptosis. Moreover, when keratinocytes
were pretreated with 1,25-(OH)2D3 in the presence of DMS the
intracellular ceramide level was further enhanced to
149.2 6 6.0 pmol per 105 cells suggesting that ceramide is the
source of formation for SPP. In addition, the cytoprotective effect
of 1,25-(OH)2D3 was completely blocked and the rate of Annexin
V+/PI± and Annexin V+/PI+ cells was enhanced. Most import-
antly, exogenous SPP overcame this inhibition, which proves the
crucial part played by SPP in the cytoprotective effect of 1,25-
(OH)2D3 (Fig 7).
Increase of Bcl-2 gene products by 1,25-(OH)2D3 and
SPP As 1,25-(OH)2D3 has been identi®ed to regulate Bcl-2
levels in thyrocytes, we investigated whether the anti-apoptotic
action of 1,25-(OH)2D3 in keratinocytes is accompanied by an
increase in Bcl-2 protein. In immunoblot analysis of Bcl-2, protein
expression was assessed at 48 h after treatment with 1,25-(OH)2D3
Figure 3. Cytoprotective effect of 1,25-(OH)2D3 against
ceramide-, UV-, and TNF-a-induced apoptosis in human
keratinocytes. Human keratinocytes were treated with vehicle or 1,25-
(OH)2D3 for 24 h. Then apoptosis was induced by addition of 25 mM
C2-cer for 3 h, UVB irradiation (11.76 mJ per cm2) or 10 ng TNF-a
per ml in the presence of 1 mg actinomycin per ml. After 24 h double
staining with Annexin V-FITC and PI was performed as described in
Materials and Methods. Data are the mean 6 SD of triplicate assays.
Figure 4. Cytoprotective effect of SPP against ceramide-induced
apoptosis in human keratinocytes. Human keratinocytes were treated
with vehicle or the indicated concentrations of SPP added as a bovine
serum albumin complex 10 min prior to the addition of 25 mM C2-cer.
After 3 h double staining with Annexin V-FITC and PI was performed.
Values are the mean 6 SD of triplicate assays. Results were repeated in
at least three independent experiments.
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and SPP (Fig 8). Indeed, 1±100 nM of 1,25-(OH)2D3 increased
Bcl-2 protein levels in a concentration-dependent manner, which is
similar to the effective dose for its cytoprotective actions.
Moreover, when cells were treated with 1 mM of 1,25-(OH)2D3
Bcl-2 protein levels were drastically diminished indicating a
cytotoxic effect of 1,25-(OH)2D3 starting at this concentration.
In agreement SPP also enhanced Bcl-2 protein levels in a
concentration-dependent manner obtaining highest levels at a
concentration of 10 mM.
DISCUSSION
The effects of 1,25-(OH)2D3 on cell growth arrest and induction of
differentiation in keratinocytes have been well characterized, but
the mechanism of its anti-proliferative and differentiating actions
has not been fully clari®ed. 1,25-(OH)2D3 was the ®rst compound
identi®ed as an inducer of sphingomyelin hydrolysis leading to
enhanced ceramide formation (Okazaki et al, 1989). In keratino-
cytes 1,25-(OH)2D3 and calcipotriol increase ceramide levels via an
autocrine mechanism by upregulation of TNF-a secretion (Geilen
et al, 1997). The anti-proliferative effect in keratinocytes is
mimicked by naturally occurring ceramides and the partial synthetic
derivative C2-cer suggesting that these sphingolipids are important
for cell growth arrest induced by 1,25-(OH)2D3 (Bielawska et al,
1992a). Well known inductors of programmed cell death, e.g.,
TNF-a or Fas-ligand and several lines of evidence suggest that
ceramide plays a regulatory part in this process and that the
formation of this sphingolipid does not appear to arise as a
consequence of activation of the cell death machinery (Hannun,
1996; Zhang et al, 1996; Dbaibo et al, 1997). Enigmatically, 1,25-
(OH)2D3 has been shown to act as both an inducer of apoptosis as
well as a protective compound of cell survival indicating that
apoptosis is not a universal response to 1,25-(OH)2D3 treatment. In
breast cancer cell lines pretreatment with 10 nM 1,25-(OH)2D3
potentiates the effects of anti-cancer drugs (Wang et al, 2000),
whereas in HL-60 cells and thyrocytes identical 1,25-(OH)2D3
concentrations make cells resistant to chemotherapeutic agents (Xu
et al, 1993; Wang et al, 1999). Previously, it has been reported that
1,25-(OH)2D3 induces apoptosis in human keratinocytes as well as
in HaCaT cells (Benassi et al, 1997; Bektas et al, 2000); however, it
should be mentioned that this induction of apoptosis became ®rst
visible after 3 d with concentrations higher than 1 mM of 1,25-
(OH)2D3. This is not contradictory to our results as we have shown
an increase of Annexin V binding and PI uptake induced by 1,25-
(OH)2D3 starting at this concentration as well. Most interestingly,
here we report for the ®rst time that treatment of keratinocytes
with lower 1,25-(OH)2D3 concentrations (1±100 nM), which are
Figure 5. In¯uence of 1,25-(OH)2D3 on
sphingosine kinase activity. Human
keratinocytes were incubated with 100 nM of
1,25-(OH)2D3 up to 24 h (A) or treated with the
indicated concentrations of 1,25-(OH)2D3 for
24 h (B). Sphingosine kinase activity was
measured as described in Materials and Methods.
Data are the mean 6 SD of triplicate assays
expressed as percent of control. The experiment
was three times independently repeated obtaining
similar results.
Table II. Effect of 1,25-(OH)2D3 on intracellular SPP levels and cytoprotection after ceramide-induced apoptosis in
human keratinocytesa
Incubation
time (h)
SPP levels after treatment
with 1,25-(OH)2D3
Cytoprotection of 1,25-(OH)2D3
against C2-cer induced apoptosis
SPP level
(pmol per 106 cells) % of control
Annexin V+/PI± and Annexin
V+/PI+ cells (%) Protection in %
0 7.1 6 0.7 100 61.5 6 7.7 0
6 6.1 6 1.9 86 53.2 6 8.4 17
12 8.0 6 0.7 113 37.1 6 5.3b 49
18 8.6 6 1.0 122 19.3 6 14.2b 85
24 9.8 6 0.9b 138 14.3 6 3.9b 95
aKeratinocytes were treated with 100 nM of 1,25-(OH)2D3 for the indicated time periods and SPP levels were subsequently measured as described in Materials and
Methods. For measurement of the cytoprotective effect keratinocytes were pretreated for the indicated time periods with 100 nM of 1,25-(OH)2D3 followed by the addition
of 25 mM of C2-cer for 3 h. Then Annexin V binding and PI uptake were measured as described. Control cells without C2-cer showed 11.5 6 3.3 Annexin V+/PI± and
Annexin V+/PI+ cells. Data are mean 6 SD of triplicate determinations.
bp < 0.05 considered signi®cant.
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effective to induce cell growth arrest and differentiation, do not
enhance apoptosis despite the formation of ceramide. Even more,
1,25-(OH)2D3 makes keratinocytes resistant to ceramide-induced
cell death.
Data presented here demonstrate that SPP mediates the survival
effect of 1,25-(OH)2D3. The anti-apoptotic effect of 1,25-
(OH)2D3 correlates with the formation of SPP, which is able to
rescue keratinocytes from ceramide-mediated cell death.
Moreover, the cytoprotective effect of 1,25-(OH)2D3 is completely
blocked by the addition of DMS, which has been identi®ed as a
competitive inhibitor of sphingosine kinase and, therefore, is used
to investigate the biologic role of SPP (Edsall et al, 1998); however,
DMS has also been shown to inhibit PKC activity in vitro (Igarashi
and Hakomori, 1989; Felding-Habermann et al, 1990; Khan et al,
1990). In keratinocytes, DMS effectively inhibits 1,25-(OH)2D3-
stimulated sphingosine kinase activity without affecting PKC
activity signi®cantly. This is in agreement with studies in U937
monoblastic leukemia cells, Swiss 3T3 ®broblasts, and PC12
pheochromocytoma cells (Edsall et al, 1998).
Currently, it is less well understood, how 1,25-(OH)2D3 and
SPP mediate their survival strategy. In HL-60 cells it has been
clearly demonstrated that a variety of prominent regulatory
components of apoptosis such as c-myc and p53 are not involved
in the protective effect of 1,25-(OH)2D3 (Wolf and Rotter, 1985;
Solary et al, 1993; Wang and Studzinski, 1997).
An important target of 1,25-(OH)2D3 and SPP may be
alterations in the levels of Bcl-2 family members. Apoptotic
response is often dependent on the ratio of apoptosis inducing (Bax,
Bcl-Xs) to apoptosis-protective members (Bcl-2, Bcl-xl, Mcl-1)
(McDonnell et al, 1996). Indeed, treatment of HL-60 cells with
1,25-(OH)2D3 results in a progressive increase of mitochondrial
Mcl-1 protein and a transient increase in Al protein level. As in
these investigations Raf-1 protein has also been detected in the
mitochondrial fractions, a recruitment of activated Raf-1 to the
mitochondria membrane takes place, which increases Mcl-1-
mediated resistance to apoptosis (Wang and Studzinski, 1997). In
this context it is of interest that SPP has been recognized as a
positive regulator of Raf-1 protein and a suppressor of Bax-protein
(Wu et al, 1995; Goetzl et al, 1999). Besides this, overexpression of
Bcl-2 protein has been shown to protect cells from C2-cer induced
apoptosis (Zhang et al, 1996). In human thyrocytes 1,25-(OH)2D3
increases Bcl-2 messenger RNA and protein levels, elevates the
Bcl-2/Bax ratio, and protects thyrocytes from apoptosis (Wang
et al, 1999), whereas in breast cancer cells 1,25-(OH)2D3 decreases
Bcl-2 expression and induces apoptosis (James et al, 1996).
In keratinocytes an increase of Bcl-2 has been shown to mediate
anti-apoptotic actions as well (Pincelli et al, 1997), whereas a
decrease induced by C2-cer is connected to an enhanced apoptotic
DNA fragmentation (Di Nardo et al, 2000). Nerve growth factor,
which is synthesized and released by keratinocytes, acts as a survival
factor through its high-af®nity receptor by altering the Bcl-2/Bax
Figure 6. DMS inhibits sphingosine kinase
activity but not PKC activity in
keratinocytes. Keratinocytes were incubated in
the absence or presence of DMS (5 mM) for 3 h
and then treated with 1,25-(OH)2D3 100 mN for
24 h. Subsequently, membrane-associated PKC
activity (A) or sphingosine kinase activity (B) was
measured as described in Materials and Methods.
Values are the mean 6 SD of triplicate assays.
The results are from one representative
experiment of three.
Figure 7. DMS inhibits the cytoprotective effect of 1,25-
(OH)2D3. Keratinocytes were treated for 24 h with or without 100 nM
of 1,25-(OH)2D3, 5 mM of DMS, and 10 mM of SPP as indicated. Then
double staining with Annexin V-FITC and PI was performed. Data
points, mean percentage Annexin V+/PI± and Annexin V+/PI+ cells
remains; bars, SD. Similar results were obtained in three additional
experiments.
Figure 8. In¯uence of 1,25-(OH)2D3 and SPP on Bcl-2 protein
expression. Total proteins were obtained from human keratinocytes
after 48 h of stimulation with 1,25-(OH2)D3 or SPP with the indicated
concentrations. Fifteen micrograms of protein per lane were loaded on a
12.5% polyacrylamide gel and western blot analysis were performed as
described in Materials and Methods. Individual bands represent protein
expression of Bcl-2 at 26 kDa.
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ratio and has been identi®ed as a very potent activator of
sphingosine kinase (Rius et al, 1997). Indeed, here we show an
anti-apoptotic action of 1,25-(OH)2D3 as well as SPP, which is
associated with an acceleration of Bcl-2 protein expression.
In analogy to the Bcl-2/Bax rheostat, a variety of investigations
implicate that the ratio of intracellular ceramide and SPP levels are a
determining factor in the fate of the cell (Cuvillier et al, 1996;
Kleuser et al, 1998). Several targets of SPP besides Raf-1 protein
activation have been elucidated. It has been suggested that the
stress-activated protein kinase (SAPK/JNK) pathway is involved in
ceramide-mediated apoptosis and SPP prevents the activation of
these kinase cascades. Moreover, SPP stimulates extracellular signal-
regulated kinases Erk1 and Erk2 suggesting that speci®c activation
of different family members of mitogen-activated protein kinases
are responsible for the opposing effects of ceramide and SPP on
apoptosis (Cuvillier et al, 1996). Additionally, SPP counteracts
activation of caspases, a family of aspartate-speci®c cysteine
proteases involved in the induction of apoptosis (Cuvillier et al,
1998).
The clinical implications of our ®ndings are complex. The main
pathophysiologic features of psoriasis include an increase in
keratinocyte proliferation and abnormal cell differentiation as well
as the presence of a dermal in¯ammatory cell ®ltrate (Lowe et al,
1995). 1,25-(OH)2D3 and calcipotriol possess the capacity to
induce cell growth arrest and differentiation.
In conclusion, the present study suggests that the inhibition of
cell growth is not a consequence of apoptosis as 1,25-(OH)2D3 has
a cytoprotective effect in keratinocytes. These ®ndings are
important for the optimal dose of 1,25-(OH)2D3 in the treatment
of hyperproliferative skin diseases. Moreover, the formation of SPP
is crucial for the anti-apoptotic effect of 1,25-(OH)2D3. An
exciting goal for future research will be to elucidate further the part
played by SPP in epidermal cells.
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